Navigation Links
Human Genome Sciences Reports Positive Data from Long-Term Treatment with LymphoStat-B(R) in Patients with Active Systemic Lupus Erythematosus
Date:11/9/2007

ed in LymphoStat-B clinical trials or other studies involving HGS products may inquire via the "Contact Us" section of the Company's Web site, http://www.hgsi.com/products/request.html, or by calling (301) 610-5790, extension 3550.

HGS, Human Genome Sciences, ABthrax, Albuferon, BLyS and LymphoStat-B are trademarks of Human Genome Sciences, Inc.

HGS Safe Harbor Statement

This announcement contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. The forward-looking statements are based on Human Genome Sciences' current intent, belief and expectations. These statements are not guarantees of future performance and are subject to certain risks and uncertainties that are difficult to predict. Actual results may differ materially from these forward-looking statements because of the Company's unproven business model, its dependence on new technologies, the uncertainty and timing of clinical trials, the Company's ability to develop and commercialize products, its dependence on collaborators for services and revenue, its substantial indebtedness and lease obligations, its changing requirements and costs associated with facilities, intense competition, the uncertainty of patent and intellectual property protection, the Company's dependence on key management and key suppliers, the uncertainty of regulation of products, the impact of future alliances or transactions and other risks described in the Company's filings with the Securities and Exchange Commission. In addition, the Company will continue to face risks related to animal and human testing, to the manufacture of ABthrax and to FDA concurrence that ABthrax meets the requirements of the ABthrax contract. If the Company is unable to meet the product requirements associated with the ABthrax contract, the U.S. govern
'/>"/>

SOURCE Human Genome Sciences, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Video: New Research Discovers Independent Brain Networks Control Human Walking
2. Lpath Demonstrates Strong Safety Profile of Lead Drug Candidate, Sphingomab(TM), in Non-Human Primates
3. Enrollment Begins on Human PK Study for Medidur(TM) FA
4. Human Genome Sciences Completes Enrollment of First Phase 3 Albuferon(R) Trial Ahead of Schedule
5. Study Confirms Limited Human-To-Human Spread of Avian-Flu Virus in Indonesia in 2006
6. Lpath Demonstrates Preclinical Efficacy of Lpathomab(TM) and Initiates Humanization Process
7. Peregrine Researchers Report Data Showing Bavituximabs Potential to Shrink Human Prostate Tumors in Model of Relapsed Disease
8. Dr. Roger Kenneth Hershline PhD MD, CEO of Global Humanceuticals, Inc. Donates New HIV Drug
9. Study Shows Plasma-Derived Human Thrombin Equivalent to Bovine Thrombin in Achieving Hemostasis in Surgery
10. Tengion Launches Second Phase 2 Clinical Trial of Regenerated Human Organ
11. Flexible Medical Systems Raises $1.2M Seed Investment for Initial Human Trials
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2015)... , May 05, 2015 Research and ... the addition of the "Clinical Laboratory,Molecular Diagnostics ... 2015 to 2019 - Latin America, Africa and ... A market that just keeps on ... benefit from the explosion in biotechnology, especially genomics. ...
(Date:5/5/2015)... May 5, 2015 Merrimack Pharmaceuticals, Inc. (Nasdaq: ... a randomized, double-blinded, placebo-controlled Phase 2 clinical trial ... ErbB3, in combination with nab-paclitaxel and gemcitabine, versus ... metastatic pancreatic cancer who have high serum levels ... the fourth leading cause of cancer death in ...
(Date:5/5/2015)... , May 5, 2015 The ... announced the recipient of its 6 th ... Volkmer, President and CEO of Ear Professionals International ... of hearing benefits in the nation, EPIC Hearing ... contracts with managed care organizations, employers, health plans, ...
Breaking Medicine Technology:Latin America, Africa and Middle East Clinical Laboratory, Molecular Diagnostics and Genomic Testing Services Market 2015-2019 2Merrimack Pharmaceuticals Announces Initiation of a Phase 2 Front-line Clinical Trial of MM-141 in Biomarker-Selected Patients with Metastatic Pancreatic Cancer 2Merrimack Pharmaceuticals Announces Initiation of a Phase 2 Front-line Clinical Trial of MM-141 in Biomarker-Selected Patients with Metastatic Pancreatic Cancer 3Merrimack Pharmaceuticals Announces Initiation of a Phase 2 Front-line Clinical Trial of MM-141 in Biomarker-Selected Patients with Metastatic Pancreatic Cancer 4EPIC Hearing Healthcare CEO Brad Volkmer Awarded 6th Annual Most Influential In Specialty Health 2
... CHICAGO , July 7 ... intellectual property brokerage division of ICAP plc (IAP.L), ... to the advanced drug formulation technology Captisol® owned ... US-issued patents and fifteen related foreign counterparts covering ...
... NEW YORK , July 7 Reportlinker.com announces that ... , , ... Opinions: HIV in Emerging Markets (Brazil, Russia, India) - Growing need ... , , ...
Cached Medicine Technology:ICAP Ocean Tomo Offers for Sale Advanced Drug Formulation Technology From CyDex Pharmaceuticals Inc. 2ICAP Ocean Tomo Offers for Sale Advanced Drug Formulation Technology From CyDex Pharmaceuticals Inc. 3Stakeholder Opinions: HIV in Emerging Markets (Brazil, Russia, India) - Growing need for second- and third-line therapies boosts commercial opportunity 2Stakeholder Opinions: HIV in Emerging Markets (Brazil, Russia, India) - Growing need for second- and third-line therapies boosts commercial opportunity 3Stakeholder Opinions: HIV in Emerging Markets (Brazil, Russia, India) - Growing need for second- and third-line therapies boosts commercial opportunity 4Stakeholder Opinions: HIV in Emerging Markets (Brazil, Russia, India) - Growing need for second- and third-line therapies boosts commercial opportunity 5Stakeholder Opinions: HIV in Emerging Markets (Brazil, Russia, India) - Growing need for second- and third-line therapies boosts commercial opportunity 6Stakeholder Opinions: HIV in Emerging Markets (Brazil, Russia, India) - Growing need for second- and third-line therapies boosts commercial opportunity 7Stakeholder Opinions: HIV in Emerging Markets (Brazil, Russia, India) - Growing need for second- and third-line therapies boosts commercial opportunity 8Stakeholder Opinions: HIV in Emerging Markets (Brazil, Russia, India) - Growing need for second- and third-line therapies boosts commercial opportunity 9Stakeholder Opinions: HIV in Emerging Markets (Brazil, Russia, India) - Growing need for second- and third-line therapies boosts commercial opportunity 10Stakeholder Opinions: HIV in Emerging Markets (Brazil, Russia, India) - Growing need for second- and third-line therapies boosts commercial opportunity 11Stakeholder Opinions: HIV in Emerging Markets (Brazil, Russia, India) - Growing need for second- and third-line therapies boosts commercial opportunity 12
(Date:5/5/2015)... San Rafael, CA (PRWEB) May 05, 2015 ... Snader in 2012, with the belief that ultimate Frisbee™ ... can be the next sport that engages the world. ... the youth level, by creating opportunities for young athletes ... makes this collaboration with MLU the perfect fit. , ...
(Date:5/5/2015)... (PRWEB) May 05, 2015 NovaSom, Inc., ... upcoming episode of Innovations with Ed Begley Jr., airing ... times TBA. , This segment will focus on NovaSom, ... Viewers will learn about their AccuSom® home sleep test, ... that provides continuous patient support and next-day test results ...
(Date:5/5/2015)... (PRWEB) May 05, 2015 Every year, news ... seasons. Turns out, the worst dry eye season is spring, ... spikes in most of the United States. The only season ... water advocate Sharon Kleyne, host of the Sharon Kleyne Hour™ ... on her radio show of May 11, 2015. Kleyne is ...
(Date:5/5/2015)... (PRWEB) May 05, 2015 McMunn ... and end-to-end automation solutions, announced today that it has ... and corporate identity. According to president and founder, Larry ... aligned with the company’s strategy for growth and expansion ... successful for the past 30 years by building close, ...
(Date:5/5/2015)... BioFit Engineered Products , a globally ... from its two latest lines at NeoCon 2015, June ... Headlining the company’s exhibit will be new Pro and ... well as the unveiling of the fifth model of ... Metzger will deliver in-booth presentations each day of the ...
Breaking Medicine News(10 mins):Health News:US Sports Camps, Nike Ultimate Camps, and Major League Ultimate Host Youth Ultimate Summer Camps in Philidelphia 2Health News:Innovations with Ed Begley, Jr. to Explore NovaSom, Inc., in Upcoming Episode 2Health News:Nature’s Tears EyeMist tear film supplement soothes dry eye caused by spring pollen season, reports inventor Sharon Kleyne 2Health News:Nature’s Tears EyeMist tear film supplement soothes dry eye caused by spring pollen season, reports inventor Sharon Kleyne 3Health News:McMunn Associates Launches New Corporate Branding with New Website 2Health News:BioFit to Introduce New Models from Latest Specialized Ergonomic Seating Lines at NeoCon 2015 2Health News:BioFit to Introduce New Models from Latest Specialized Ergonomic Seating Lines at NeoCon 2015 3
... D. Eilers Professor of Medicine and Health Care Management and ... the Wharton School, was presented with the Alpha Omega Alpha ... of Medical Colleges (AAMC). The award was presented on ... Recognizing Dr. Asch, the AAMC said, "Dr. ...
... don,t help those with existing disease , TUESDAY, Nov. ... from a young age might prevent early signs of ... study in mice. , Recent research suggests that the ... in the development of Alzheimer,s. In the new study, ...
... ... Dr Cheryl Effron of Cosmetic Dermatology of Orange County offers Sculptra Aesthetic@ at affordable ... (PRWEB) ... of Cosmetic Dermatology of Orange County offers Sculptra Aesthetic@ at affordable prices., , , ...
... ... to have policyholders select and pay extra for either a plan which covers abortion or ... ... over abortion coverage and the possibility that the same thing could happen again in the ...
... ... a North American company, is expanding its cutting edge vibration exercise technology into South ... the Pro Elite, Air Reflex and Contour Plus, are now available in South America. ... (Vocus) November ...
... ATLANTA Emory University Rollins School of Public Health ... topics at the American Public Health Association,s annual meeting ... national recommendations that a physician screen chest pain patients ... Department (ED). Additional public health research findings from ...
Cached Medicine News:Health News:David A. Asch, M.D., M.B.A., receives AAMC Distinguished Teacher Award 2Health News:FDA-Approved Sculptra@ Now Offers by Orange County Dermatologist Dr. Cheryl Effron 2Health News:“Think Outside the Box” Blog Proposes Better Abortion Compromise for Health Reform 2Health News:WAVE's Revolutionary Whole-Body Advanced Vibration Exercise Is Now Available in South America 2Health News:Some chest pain patients wait longer than 10 minutes to see ER physician 2
... 2000 Pipette is a synonym for pipetting ... robust design, and superior operating comfort. Its ... the measuring stroke and blow-out as well ... system ensures utmost accuracy and precision. Ejection ...
Inquire...
... The Eppendorf Reference Series 2000 Pipette ... smooth stroke, a compact and robust design, ... button is used to operate the measuring ... the tip. Product features:Eppendorf "pipette/tip" system ensures ...
... The Eppendorf Reference Series 2000 Pipette is ... stroke, a compact and robust design, and ... is used to operate the measuring stroke ... tip. Product features:Eppendorf "pipette/tip" system ensures utmost ...
Medicine Products: